Understanding Tirzepatide Tirzepatide is a groundbreaking weight loss injection that simultaneously targets GLP-1 and GIP receptors to control appetite and improve energy metabolism
CrossRef The GutLiver Axis in Metabolic DysfunctionAssociated Steatotic Liver Disease: From Mechanistic Insights to Precision Therapeutics Shaoliang Zhu, Mengjie Zou, Qijun Wu, Yan Zou, Tingting Tan, Zhangnan Huang, Zheng Gong, Honglin Luo, Xiaofeng Dong The FASEB Journal .2026;[Epub] CrossRef Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes Konstantinos Malandris, Konstantinos Charalampidis, Rohit Loomba, Emmanouil Sinakos Current Diabetes Reports .2026;[Epub] CrossRef Association between weekend catch-up sleep and Metabolic dysfunction-associated steatotic liver disease in US adults Jinlong Chen, Wei Wang, Jie He, Xinxin Fang Clinical and Experimental Medicine .2026;[Epub] CrossRef Ginsenoside Rg1 alleviates MASH by targeting GLS2 to enhance PINK1/Parkin-mediated mitophagy and improve mitochondrial function Zhijian Wang, Yinuo Wang, Peiyun Peng, Huating Luo, Liuling Xiao, Wenxiang Huang Biochemical Pharmacology .2026
It acts as a signaling peptide, helping support fibroblast activity and the production of collagen, elastin and moisture-binding components that contribute to firmer, smoother and more hydrated-looking skin
Muller FL, Lustgarten MS, Jang Y, Richardson A, Van Remmen H
ITIH4 serum concentration increases during acute-phase processes in human patients and is up-regulated by interleukin-6 in hepatocarcinoma HepG2 cells
